Hot Japanese Companies To Buy Right Now

FRANKFURT -- Germany�� Siemens and Japan�� Mitsubishi Heavy Industries and Hitachi are preparing a joint offer for Alstom�� energy business in a challenge to General Electric (GE), according to a published media report Sunday.

Siemens and Mitsubishi Heavy announced their partnership Wednesday, promising to submit a bid to Alstom�� board by Monday, but they offered no details of how the partnership would work or what their offer would look like.

Later in the week, Japan�� Hitachi said it would work with Mitsubishi Heavy on a possible bid.

The three are preparing an offer that will give Siemens Alstom�� gas turbines and allow Mitsubishi and Hitachi to expand their steam turbine and hydro business operations, Bloomberg reported Sunday, citing people familiar with the situation. Siemens would pay cash for the gas turbines, while the two Japanese partners would combine their steam turbines and hydro businesses with Alstom�� and then take a minority stake in the entity, Bloomberg also reported.

The board of Siemens was scheduled to meet Sunday and was expected to approve the offer, Bloomberg said. Also citing anonymous sources familiar with the situation, The Wall Street Journal reported Sunday that Siemens and Mitsubishi were working on a joint offer for Alstom's energy business that they would make Monday and that would also have Siemens transfer its rail business to Alstom. A joint offer would threaten GE�� existing $17 billion offer for Alstom�� energy assets. Alstom said at the end of April that is supports GE's cash offer but would wait to see what Siemens offered. Shares of GE closed Friday up 8 cents at $27.04. Siemens Lands New Partner to Unplug General Electric From Alstom

Best Trucking Companies To Invest In Right Now: Sanofi(SNY)

sanofi-aventis engages in the discovery, development, and distribution of therapeutic solutions to improve the lives of everyone. The company offers a range of healthcare assets, including a broad-based product portfolio in prescription drugs, OTC/OTX, generics, vaccines, and animal health. It has a strategic alliance with Regulus Therapeutics Inc. to discover, develop, and commercialize micro-RNA therapeutics, initially in fibrosis. The company was founded in 1970 and is headquartered in Paris, France.

Advisors' Opinion:

• [By Rich Smith]

  Ahh ... ahh ... achoo!
  For one thing, it bought a whole lot of flu drugs to treat flu bugs. On Monday, the DoD awarded twin contracts for flu vaccines to a pair of foreign Big Pharma producers. France's Sanofi (NYSE: SNY  ) was awarded a $14 million contract for flu vaccines. Switzerland's Novartis (NYSE: NVS  ) got a similar $14 million order.

• [By Kanak Kanti, De]

  Teva's competition
  Teva will still face competition in the colorectal cancer generic market. The company's version of Xeloda is expected to compete with cytotoxic agents such as oxaliplatin, which is a generic version of French drugmaker Sanofi's (NYSE: SNY  ) Eloxatin/Eloxatine. In 2012, sales of Eloxatin totaled $1.3 billion. Generic competition has had a major impact on Eloxatin, however, with sales falling to $159 million in the first half of 2013.

• [By Brian Orelli]

  Like a product? Flip over the package and see who makes it. The flea protection Frontline, for instance, is made by Merial, Sanofi's (NYSE: SNY  ) animal health division. Frontline's competitor, Advantage, is sold by Bayer.

• [By Keith Speights]

  Sanofi (NYSE: SNY  ) currently dominates the market with Lantus. The French drugmaker also markets Apidra, but hasn't experienced nearly as much success with the product.

Hot Japanese Companies To Buy Right Now: Opko Health Inc(OPK)

OPKO Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico. It provides a range of solutions, including molecular diagnostics tests, proprietary pharmaceuticals, and vaccines to diagnose, treat, and prevent neurological disorders, infectious diseases, oncology, and ophthalmologic diseases. The company offers molecular diagnostic platform technology for the rapid identification of molecules or immunobiomarkers; Alzheimer?s test for Alzheimer?s diagnostic; and protein-based influenza vaccines to provide multi-season and multi-strain protection against various influenza virus strains, such as seasonal influenza strains, as well as global influenza pandemic strains which include swine flu, and avian flu. It also offers Oligonucleotide Therapeutics for the treatment of various illnesses, including cancer, heart disease, metabolic disorders, and genetic anomalies; and oligosaccharide for asthma and chronic obstructive pulmonary diseases. In addition, the company provides Rolapitant, a potent and antagonist; neurokinin-1, which has completed Phase II clinical trials for prevention of chemotherapy induced nausea and vomiting, and post-operative induced nausea and vomiting; and SCH 900978 that has completed Phase II clinical trials for chronic cough. Further, it offers bevasiranib, a drug candidate for the treatment of Wet AMD; and develops Aquashunt, a shunt to be used in the treatment of glaucoma. Additionally, the company involves in the development, commercialization, and sale of ophthalmic diagnostic and imaging systems, and instrumentation products. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

Advisors' Opinion:

• [By John Udovich]
  SafeStitch Medical Inc. A developer and marketer of�best in class disposable medical devices to advance minimally invasive surgery for hernia repair, treatment of obesity and other gastroesophageal disorders, small cap SafeStitch Medical has developed and obtained FDA approval to market the AMID Hernia Fixation Device (HFD) for both inguinal and ventral hernia repairs. SafeStitch Medical has a couple of people behind it who are also involved in OPKO Health (NYSE: OPK)���a NYSE company with a $2.5 billion market cap. Moreover, these and other insiders were heavy buyers of the stock during the last private placement. On Wednesday, sank 18.57% to $0.855 (SFES has a 52 week trading range of $0.21 to $1.49 a share) for a market cap of $52.75 million but the stock is up 288.6% since the start of the year after surging this summer, up 42.5% over the past year and down 64.4% over the past five years.�

• [By Rich Smith]

  Miami, Fl.-based Opko Health (NYSE: OPK  ) took a 10% stake in Russian peer pharmaceutical firm OAO Pharmsynthez, Opko announced Thursday.

Hot Japanese Companies To Buy Right Now: Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Incorporated operates as a biotechnology company. It principally engages in the development and acquisition of royalty revenue generating assets. The company engages in the research, milestone, and royalty revenue activities resulting from its collaborations with pharmaceutical partners. The collaborations primarily include ongoing clinical programs at Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Merck & Co., Cephalon, Inc, and Celgene. These partnered product candidates are being studied for the treatment of indications, such as thrombocytopenia, rheumatoid arthritis, chronic obstructive pulmonary disease, asthma, osteoporosis, menopausal symptoms, and Alzheimer?s disease. Ligand Pharmaceuticals Incorporated receives royalties principally on sales of Avinza from Pfizer, Promacta from GlaxoSmithKline, and Viviant /Conbriza from Pfizer. The company through its subsidiary, CyDex Pharmaceuticals, Inc., offers four marketed products, as well as has one approved product, a portfolio of partnered drug development programs, an internal pipeline of proprietary drugs, and the Captisol drug formulation platform technology. Ligand Pharmaceuticals Incorporated was formerly known as Progenx Inc. and changed its name in 1989. The company was founded in 1987 and is based in La Jolla, California.

Advisors' Opinion:

• [By Garrett Cook]

  Healthcare shares dropped by 0.34 percent in the US market on Wednesday. Top losers in the sector included POZEN (NASDAQ: POZN), down 7.57 percent, and Ligand Pharmaceuticals (NASDAQ: LGND), off 6.77 percent.

• [By Louis Navellier]

  QCOR is a strong buy at the current price.

  Biotech Stocks to Buy: Ligand Pharmaceuticals (LGND)

  Ligand Pharmacuticals (LGND) is a biotech company that focuses on acquisition and development of royalty revenue generating assets in the United States. Ligand has relationships with most of the leading drug companies including GlaxoSmithKline (GSK), Merck (MRK), Bristol-Myers (BMY), Eli Lilly (LLY) and others.

• [By Garrett Cook]

  Healthcare shares dropped by 0.34 percent in the US market on Wednesday. Top losers in the sector included POZEN (NASDAQ: POZN), down 7.2 percent, and Ligand Pharmaceuticals (NASDAQ: LGND), off 5.5 percent.

Hot Japanese Companies To Buy Right Now: Melrose Industries PLC (MLSPF)

Melrose Industries PLC acquires manufacturing businesses and improves them. The Company operates in four divisions: Energy, Lifting, Other Industrial and Elster. The Energy division is a supplier of turbogenerators, other electricity generating machinery, switchgear, transformers and power infrastructure equipment. Its products consist of power management and excitation systems; power and system transformers, and aftermarket servicing. Lifting division is a supplier of lifting fittings, blocks and custom engineered material handling products and supplier for wire and wire rope. Other Industrial division has manufacturing businesses across the housing, construction and scrap processing sectors. Elster is a provider of gas control equipment and related communications, gas, electricity and water meters and software solutions. In January 2014, the Company disposed Harris Waste Management Group, Inc. to Avis Industrial Corporation. Advisors' Opinion:

• [By Roland Head]

  Today, I'm going to take a look at�Melrose Industries� (LSE: MRO  ) (NASDAQOTH: MLSPF  ) , an unusual company which specialises in turning around manufacturing businesses, before selling them on. Melrose's current portfolio of businesses contains German utility meter maker Elster, Brush Turbo Generators and Marelli Motori, which make electric motors and generators, and Bridon, which makes rope and wire products used in the oil and gas industry.

Hot Japanese Companies To Buy Right Now: Dell Inc.(DELL)

Dell Inc. provides integrated technology solutions in the information technology (IT) industry worldwide. It designs, develops, manufactures, markets, sells, and supports mobility and desktop products, including notebooks, workstations, tablets, smartphones, and desktop PCs, as well as servers and networking products. The company offers storage solutions, including storage area networks, network-attached storage, direct-attached storage, and various backup systems. It also provides IT and business services comprising transactional services, such as support, managed deployment, enterprise installation, and configuration services; outsourcing services, including data center and systems management, network management, life cycle application development and management, and business process outsourcing services; and project-based services consisting of IT infrastructure, applications, business process, and business consulting services. In addition, the company offers third-part y software products comprising operating systems, business and office applications, anti-virus and related security software, and entertainment software; and peripheral products, such as printers, televisions, notebook accessories, mouse, keyboards, networking and wireless products, and digital cameras. Further, it provides financial services, including originating, collecting, and servicing customer receivables related to the purchase of its products and third-party technology products. The company sells its products and services directly through its sales representatives, telephone-based sales, and online sales; and through retailers, third-party solution providers, system integrators, and third-party resellers. It serves corporate businesses, law enforcement agencies, small and medium businesses, consumers, and public institutions that include government, education, and healthcare organizations. Dell Inc. was founded in 1984 and is headquartered in Round Rock, Texas.

Advisors' Opinion:

• [By Mathew Schwartz]

  Bloomberg via Getty Images • Here's the last thing you want as a feature on your slick new new laptop: the scent of a litter box. Seems a number of Dell (DELL) customers have been complaining that their Latitude 6430u Ultrabooks smell strongly of cat urine. Dell is assuring everyone that the odor is unrelated to pee of any kind, nor was there a biological contaminant involved. Just a problem in the manufacturing process, which it has sorted out. • Speaking of smells, among expats, China now ranks No. 1 for providing the best overseas experience -- its smog and other pollution issues notwithstanding -- according to HSBC's annual Expat Explorer Survey. Countries were ranked based on a variety of categories related to economics, experience and raising children abroad. China jumped from No. 7 last year to knock off 2012 top dog Singapore, which slipped to No. 3. • Thanks to a class-action settlement between video game titan Electronic Arts (EA) and a group of former college football players, we can now put a price tag on our high-caliber college athletes: Somewhere in the neighborhood of $133 to $200 apiece. Based on the $40 million its setting aside to cover the cost of the deal, that's about what EA will be paying each of the 200,000 to 300,000 past and current student-athletes whose likenesses were used without their consent in NCAA Football games by EA Sports. (And yes, after this year, EA will stop making new games in the franchise.) • It's good news, bad news out of Washington. Good news: The federal deficit for 2013 will be the smallest it's been since 2008, according to the Treasury. The $680 billion deficit is less than half of the record high hit in 2009 of $1.4 trillion. Bad news: While about 4/5 of the decline was due to higher revenues from taxes (yay, improving economy!), the rest came from the painful sequester (those across-the-board spending cuts that were designed to be so horrible that they'd force Congress to find a bet

• [By Rick Munarriz]

  There were some notable moves during the period. Lenovo overtook Hewlett-Packard (NYSE: HPQ  ) to ship the most computers worldwide during the past three months. Dell (NASDAQ: DELL  ) remains a distant third.

Hot Japanese Companies To Buy Right Now: Gas Natural Inc. (EGAS)

Gas Natural Inc. engages in the distribution and sale of natural gas to residential, commercial, and industrial customers in Montana, Wyoming, North Carolina, and Maine. The company distributes approximately 30 billion cubic feet of natural gas to approximately 63,500 customers through regulated utilities operating in Montana, Wyoming, Maine, North Carolina, Ohio, and Pennsylvania. It also markets approximately 1.3 billion cubic feet of natural gas to commercial and industrial customers in Montana and Wyoming, and manages midstream supply and production assets for transportation customers and utilities. In addition, the company owns a 48% working interest in 160 natural gas producing wells and gas gathering assets. Further, it owns the Shoshone interstate and the Glacier gathering natural gas pipelines located in Montana and Wyoming. The company was formerly known as Energy, Inc. and changed its name to Gas Natural Inc. in July 2010. Gas Natural Inc. was founded in 1909 an d is headquartered in Great Falls, Montana.

Advisors' Opinion:

• [By David Dittman]

  Gas Natural Inc (NYSE: EGAS) distributes and sells natural gas to approximately 73,000 residential, commercial and industrial customers through regulated utilities operating in Montana, Wyoming, Ohio, Pennsylvania, Maine, North Carolina and Kentucky.

Hot Japanese Companies To Buy Right Now: ICU Medical Inc.(ICUI)

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in infusion therapy, oncology, and critical care applications. The company?s product line includes custom infusion systems, closed delivery systems for hazardous drugs, needleless infusion connectors, catheters, and cardiac monitoring systems. Its products enhance patient outcomes by preventing bloodstream infections, protecting healthcare workers and patients from exposure to infectious diseases or hazardous drugs, and monitoring the cardiac output of critical care patients. The company offers intravenous (I.V.) therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient?s vein for use in hospitals and ambulatory clinics; CLAVE product, a needleless I.V. connection device, which would be used with conventional peripheral or central vascular access systems for venous and arterial applications; custom infusion sets. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including disposable pressure-sensing devices, blood sampling systems, angiography kits, sensory catheters, pulmonary artery thermodilution catheters, and multi-lumen central venous catheters. In addition, the company provides TEGO for use in dialysis; a line of oncology products, including Spiros male luer connector device; the Genie vial access device; and custom I.V sets and ancillary products for chemotherapy. ICU Medical, Inc. sells its products to medical product manufacturers and independent medical supply distributors, as well as directly to the end customers worldwide. The company was founded in 1984 and is headquartered in San Clemente, California.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of ICU Medical (NASDAQ: ICUI  ) �-- a medical device maker in the fields of infusion therapy, oncology, and critical care -- soared as much as 17% on a report that the company could be exploring a sale.

• [By CRWE]

  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, reported that Company management will be presenting at the UBS Global Life Sciences Conference to be held on September 19-20, 2012, at the Grand Hyatt Hotel, New York.